Australia markets close in 4 hours 42 minutes

Lifeist Wellness Inc. (NXTTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0404+0.0055 (+15.76%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0349
Open0.0312
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0300 - 0.0404
52-week range0.0300 - 0.1840
Volume11,802
Avg. volume138,636
Market cap16.547M
Beta (5Y monthly)1.46
PE ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings date27 July 2022 - 01 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Lifeist’s CannMart Labs Provides Update on its Expanding Proprietary Cannabis Product Offering

    TORONTO, June 03, 2022 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today provided updates with respect to its wholly owned subsidiary CannMart Labs Inc. (“Labs”). Continued Progress Commercializing Proprietary Brands Commercializing proprietary 2.0 branded cannabis products is a key pa

  • GlobeNewswire

    Lifeist Announces Sale of Non-core Swedish Subsidiary Findify

    Disposition Further Sharpens Focus on B2B Recreational Cannabis and NutraceuticalsTORONTO, May 26, 2022 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale (the “Transaction”) of Findify AB (“Findify”), the Company’s Swedish subsidiary that operates an AI-powered produ

  • GlobeNewswire

    Lifeist Reports First Quarter 2022 Financial Results

    Continued Focus on Gross Margin Expansion Showing SuccessTORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended February 28, 2022 (“Q1 2022”) compared to the same period last year (“Q1 2021”). All financial fi